- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Hotline gives financial help, AMD information
East Hanover, NJ—Novartis Ophthalmics is offering its Visudyne Access Network to help patients with age-related macular degeneration (AMD) get information about their disease.
East Hanover, NJ-Novartis Ophthalmics is offering its Visudyne Access Network to help patients with age-related macular degeneration (AMD) get information about their disease.
The program offers a free patient education component called MySight, with a 24-hour, toll-free hotline featuring recorded tips about treatment. It also provides financial assistance to cover the Medicare co-pay or cost of the treatment through a Patient Assistance Program and Alternate Funding Solutions.
For physicians, the network provides a reimbursement hotline to answer questions regarding reimbursement of verteporfin for injection (Visudyne, Novartis Ophthalmics/QLT PhotoTherapeutics). It also offers medical information, product information, and express delivery of the drug through a toll-free hotline and distribution system.
